Risk of subsequent cancer following invasive or in situ squamous cell skin cancer

Annals of Epidemiology

Volumn 12, Issue 7, 2002, Pages 469-475

  Efird, Jimmy Thomas ^a   Friedman, Gary D ^a,c   Habel, Laurel ^b   Tekawa, Irene S ^b   Nelson, Lorene M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DIVISION OF RESEARCH   (United States)

^c HRP Redwood Bldg T265 ^*  (United States)

Author keywords

Follow Up Study; Neoplasms; Squamous Cell Skin Cancer

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CANCER DIAGNOSIS; CANCER RISK; CARCINOMA IN SITU; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; EDUCATION; FEMALE; FOLLOW UP; HEALTH MAINTENANCE ORGANIZATION; HUMAN; LIP CANCER; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MOUTH CANCER; MULTIVARIATE ANALYSIS; OCCUPATIONAL EXPOSURE; PHARYNX CANCER; PRIORITY JOURNAL; QUESTIONNAIRE; RETROSPECTIVE STUDY; SKIN CANCER; SMOKING; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; UROGENITAL TRACT CANCER;

AGED; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASMS, SECOND PRIMARY; RISK; SKIN NEOPLASMS; UNITED STATES;

EID: 0036790935     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-2797(01)00276-9     Document Type: Article

References (31)

1. Preston D.S., Stern R.S. Nonmelanoma cancers of the skin. N Engl J Med. 327:1992;1649-1662.
2. Schwartz R.A., Stoll H.L. Squamous cell carcinoma. Freedberg I.M., Eisen A.Z., Wolff K., Austen K.F., Goldsmith L.A., Katz S.A.I.et al. Fitzpatrick's Dermatology in General Medicine. v. 1. 1999;840-856 McGraw-Hill Health Professions Division, New York.
3. Paletta F.X. Squamous cell carcinoma of the skin. Mandel M.A. Clinics in Plastic Surgery. 1980;313-336 W.B. Saunders Company, Philadelphia.
4. Gilliland M., Zarem H. Cutaneous malignancies. Basal and squamous cell carcinoma Schimpff S.C., Moossa A.R., Robson M.C. Comprehensive Textbook of Oncology. 1991;1365-1374 Williams & Wilkins, Baltimore, MD.
5. Fraser M.C., Hartge P., Tucker M.A. Melanoma and nonmelanoma skin cancer. Epidemiology and risk factors Semin Oncol Nurs. 7:1991;2-12.
6. Frisch M., Melbye M. New primary cancers after squamous cell skin cancer. Am J Epidemiol. 141:1995;916-922.
7. Levi F., Randimbison L., La Vecchia C., Erler G., Te V.C. Incidence of invasive cancers following squamous cell skin cancer. Am J Epidemiol. 146:1997;734-739.
8. Adami J., Frisch M., Yuen J., Glimelius B., Melbye M. Evidence of an association between non-Hodgkin's lymphoma and skin cancer. BMJ. 310:1995;1491-1495.
9. Karagas M.R., Greenberg E.R., Mott L.A., Baron J.A., Ernster V.L. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer. Cancer Epidemiol Biomark Prev. 7:1998;157-161.
10. Kahn H.S., Tatham L.M., Patel A.V., Thun M.J., Heath C.W. Jr. Increased cancer mortality following a history of nonmelanoma skin cancer. JAMA. 280:1998;910-912.
11. Hiatt R.A., Friedman G.D. The frequency of kidney and urinary tract diseases in a defined population. Kidney Int. 22:1982;63-68.
12. Krieger N. Overcoming the absence of socioeconomic data in medical records. Am J Public Health. 82:1992;703-710.
13. Côté R.A., College of American Pathologists SNOMED International. The Systematized Nomenclature of Human and Veterinary Medicine. v. 1:1993;College of American Pathologists, Northfield, IL.
14. Friedman G.D., Quesenberry C.P. Jr. Spousal concordance for cancer incidence. A cohort study Cancer. 86:1999;2413-2419.
15. Collen M.F., Davis L.F. The multitest laboratory in health care. J Occup Med. 11:1969;355-360.
16. Percy C.L., Van Holten V., Muir C.S. International classification of diseases for oncology = ICD-O. Geneva: World Health Organization; 1990:144.
17. Friedman G.D., Habel L.A., Boles M., McFarland B.H. Kaiser Permanente Medical Care Program. Division of Research, Northern California, and Center for Health Research, Northwest Division Strom B.L. Pharmacoepidemiology; 3rd ed:2000;263-283 John Wiley & Sons, New York.
18. Karaffa M.C. ICD-9-cm. International classification of diseases, 9th revision, clinical modification, 3rd ed., v. 1-3 Karaffa M.C. Practice Management Information Corporation, United States. 1991;1700 Health Care Financing Administration, Los Angeles, CA.
19. Crowder M.J., Kimber A.C., Smith R.L., Sweeting T.J. Statistical Analysis of Reliability Data. London: Chapman & Hall; 1991:250.
20. Kripke M.L. Immunologic mechanisms in UV radiation carcinogenesis. Klein G., Weinhouse S. Advances in Cancer Research. 1981;69-106 Academic Press, New York.
21. Penn I. Tumors of the immunocompromised patient. Annu Rev Med. 39:1988;63-73.
22. Scotto J., Fears T.H., Kraemer K.H., Fraumeni J.F. Nonmelanoma skin cancer. Schottenfeld D., Fraumeni J.F. Cancer Epidemiology and Prevention. 1996;1313-1330 Oxford University Press, New York.
23. Greene M.H., Wilson J. Second cancer following lymphatic and hematopoietic cancers in Connecticut, 1935-82. Natl Cancer Inst Monogr. 68:1985;191-217.
24. Kaldor J.M., Day N.E., Band P., Choi N.W., Clarke E.A., Coleman M.P.et al. Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease. An international collaborative study among cancer registries Int J Cancer. 39:1987;571-585.
25. Preston-Martin S., Thomas D.C., White S.C., Cohen D. Prior exposure to medical and dental x-rays related to tumors of the parotid gland. J Natl Cancer Inst. 80:1988;943-949.
26. Spitz M., Trizna Z. Molecular epidemiology and genetic predisposition for head and neck cancer. Harrison L.B., Sessions R.B., Hong W.K. Head and Neck Cancer. A Multidisciplinary Approach:1999;11-22 Lippincott-Raven, Philadelphia.
27. Mashberg A., Samit A.M. Early detection, diagnosis, and management of oral and oropharyngeal cancer. CA Cancer J Clin. 39:1989;67-88.
28. Schottenfeld D. Concluding commentary for the International Workshop on Multiple Primary Cancers. Cancer. 40:1977;1982-1985.
29. Dobson RL, Pinto JS. Arsenical carcinogenesis. In: Montagna W, Dobson RL, eds. Carcinogenesis: Proceedings of a Symposium on the Biology of Skin. University of Oregon Medical School, 1965. v. vii. Oxford: Pergamon Press; 1966:237-244.
30. Halpern A.C., Myskowski P.L. Malignant cutaneous tumors. Dale D.C., Federman D.D. Scientific American Medicine. 1999;2X1-2X12 Scientific American, Inc, New York.
31. U.S. Preventive Services Task Force Guide to Clinical Preventive Services. A Report of the U.S. Preventive Services Task Force:1996;Williams & Wilkins, Baltimore, MD.